Kathryn Chaloner | Academic Influence

Kathryn Chaloner's AcademicInfluence.com Rankings

Kathryn Chaloner

Mathematics

#7448

World Rank

#10125

Historical Rank

#2051

USA Rank

Statistics

#959

World Rank

#1053

Historical Rank

#197

USA Rank

mathematics Degrees

Download Badge

Mathematics

Kathryn Chaloner's Degrees

PhD Statistics University of California, Berkeley
Masters Statistics University of California, Berkeley
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Kathryn Chaloner Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Kathryn Mary Chaloner was a British-born American statistician. Chaloner was a statistics researcher who developed methods in Bayesian experimental design, and well known for her work on HIV/AIDS, infectious diseases, and women's health. She was a board member of the National Alliance for Doctoral Studies in the Mathematical Sciences, a group of faculty working towards inclusion and diversity in the doctoral-level mathematical sciences. She led an initiative in statistical sciences to broaden participation in doctoral-level studies in statistics and biostatistics.

(See a Problem?)

Kathryn Chaloner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bayesian Experimental Design: A Review (1995) (1845)
Optimal Bayesian design applied to logistic regression experiments (1989) (458)
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia (2016) (438)
Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. (1998) (319)
A Bayesian approach to outlier detection and residual analysis (1988) (201)
Changes in women's physical health during the first postpartum year. (1993) (153)
Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis (2010) (149)
The relationship of women's postpartum mental health to employment, childbirth, and social support. (1994) (145)
Optimum experimental designs for properties of a compartmental model. (1993) (135)
Optimal Bayesian Experimental Design for Linear Models (1984) (125)
Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis (2006) (119)
Graphical Elicitation of a Prior Distribution for a Clinical Trial (1993) (118)
Assessment of a Beta Prior Distribution: PM Elicitation (1983) (117)
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial (2001) (93)
The Equivalence of Constrained and Weighted Designs in Multiple Objective Design Problems (1996) (92)
Bayesian design for accelerated life testing (1992) (87)
Bayesian Experimental Design for Nonlinear Mixed‐Effects Models with Application to HIV Dynamics (2004) (84)
Quantifying and documenting prior beliefs in clinical trials (2001) (82)
Mothers' experience with household roles and social support during the first postpartum year. (1994) (75)
Antibody repertoire development in fetal and neonatal piglets XXI. Usage of most VH genes remains constant during fetal and postnatal development. (2011) (74)
Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. (2013) (66)
Older persons' opinions about life-sustaining procedures in the face of dementia. (1999) (63)
em Bayesian analysis in statistics and econometrics (1997) (63)
D- and c-optimal designs for exponential regression models used in viral dynamics and other applications (2003) (62)
Bayesian analysis in statistics and econometrics : essays in honor of Arnold Zellner (1996) (61)
A note on optimal Bayesian design for nonlinear problems (1993) (61)
A Bayesian approach to the estimation of variance components for the unbalanced one-way random model (1987) (46)
Bayesian approaches for monitoring clinical trials with an application to toxoplasmic encephalitis prophylaxis (1993) (40)
The little brown bat, M. lucifugus, displays a highly diverse V H, D H and J H repertoire but little evidence of somatic hypermutation. (2011) (40)
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy (2009) (40)
Bayesian residual analysis in the presence of censoring (1991) (40)
Effect of Primer Selection on Estimates of GB Virus C (GBV-C) Prevalence and Response to Antiretroviral Therapy for Optimal Testing for GBV-C Viremia (2006) (39)
Some properties of the dirichlet-multinomial distribution and its use in prior elicitation (1987) (38)
Bayesian Analysis of a Population HIV Dynamic Model (2002) (38)
Phase 3 trial of human islet‐after‐kidney transplantation in type 1 diabetes (2020) (37)
Bayesian design for estimating the turning point of a quadratic regression (1989) (37)
GB Virus C Infection Is Associated with Altered Lymphocyte Subset Distribution and Reduced T Cell Activation and Proliferation in HIV-Infected Individuals (2012) (36)
Effect of GB virus C on response to antiretroviral therapy in HIV‐infected Brazilians * (2006) (32)
Optimal designs and limiting optimal designs for a trinomial response (2004) (30)
Family practice residents' maternity leave experiences and benefits. (1995) (26)
Assessment of a beta prior distribution (1983) (24)
Elicitation, Monitoring, and Analysis for an AIDS Clinical Trial (1995) (21)
Detecting qualitative interaction: A Bayesian approach (2010) (21)
Constrained design strategies for improving normal approximations in nonlinear regression problems (2002) (20)
Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae. (2013) (19)
Women's postpartum maternity benefits and work experience. (1995) (16)
Imputation methods for doubly censored HIV data (2009) (15)
Growth of Hmong children. (1996) (14)
Optimal Designs for a Continuation-ratio Model (2001) (14)
GB virus C infection and non‐Hodgkin lymphoma: important to know but the jury is out (2010) (12)
A Bayesian stopping rule for a single arm study: With a case study of stem cell transplantation (2006) (12)
A copula model for bivariate hybrid censored survival data with application to the MACS study (2010) (11)
Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial (2013) (9)
GB virus C infection and survival in the Amsterdam Cohort Study. (2005) (8)
GB virus C and survival in HIV-positive people. (2004) (7)
A Bayesian analysis of doubly censored data using a hierarchical Cox model (2008) (7)
DESIGN OF POPULATION STUDIES OF HIV DYNAMICS (2005) (5)
A geometric method for singular c-optimal designs (2003) (5)
Using Prior Opinions to Examine Sample Size in Two Clinical Trials (2002) (3)
Design for a trinomial response to dose (2006) (3)
Shorter ultrasonic femur lengths in Hmong fetuses (1998) (3)
A note on optimal designs for two or more treatment groups (2004) (2)
A sequential classification rule based on multiple quantitative tests in the absence of a gold standard (2016) (2)
A Comparison of Two Current Awareness Methods. (1980) (1)
Optimal Bayesian Design for Non-Linear Estimation (1986) (1)
Making Diagnoses Based on Multiple Diagnostic Tests Without a Gold Standard (2012) (1)
Effect of Primer Selection on Estimates of GB Virus C (GBV-C) Prevalence and Response to Antiretroviral Therapy for Optimal Testing for GBV-C Viremia (2006) (0)
HIV-related peripheral neuropathy pain treated with acupuncture and amitriptyline (1999) (0)
Network for Excellence in Neuroscience Clinical Trials, NeuroNEXT: Concept to Implementation (P04.245) (2013) (0)
Bayesian analysis and classification of two enzyme‐linked immunosorbent assay tests without a gold standard (2013) (0)
StatFest 2009 meets in the field of dreams (2010) (0)
M ay 2 01 6 Bayesian D-optimal designs for error-in-variables models to the memory of (2016) (0)
The non-orthogonal design of experiments. Discussions. Reply (1990) (0)
Reply to George and to Stapleton et al. Reply on: GB virus C coinfection and HIV-1 disease (2005) (0)
Correction: Optimal Bayesian Experimental Design for Linear Models (1985) (0)
Comments on ‘Bayesians in clinical trials: Asleep at the switch’ by Lemuel A. Moyé, Statistics in Medicine (2008) (0)

This paper list is powered by the following services:

Other Resources About Kathryn Chaloner

en.wikipedia.org

What Schools Are Affiliated With Kathryn Chaloner?

Kathryn Chaloner is affiliated with the following schools: